Health Care & Life Sciences


Eli Lilly making renewed push in biotech field, where it once pioneered

August 16, 2014
Lilly expects to soon announce late-stage clinical trial results for two biotech drugs designed to slow the inflammation caused by autoimmune diseases. By the end of the year, it will announce results for a third.More.

St. Vincent considers $14M sports performance facility at Marian

September 2, 2014
Marian University, St. Vincent Health and four amateur sports groups have entered into formal discussions that could result in major developments at the northwest-side campus, the university announced Tuesday.More.

Feds: AIT's Evans 'unjustly enriched' himself in sale to employees

September 2, 2014
Just three months before the parent company of AIT Laboratories was sold in 2009 to its employees for $90 million, it was appraised for $17.1 million, according to a U.S. Department of Labor lawsuit.More.

Blood Center retrenches after losing major clients to Red Cross

August 30, 2014
The Indiana Blood Center is set to lose more than one-third of its revenue early next year, as three hospital systems bolt for cheaper prices offered by the American Red Cross.More.



In Depth Report

BioCrossroads has stoked state's life sciences industry, but challenges remainRestricted Content

In the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies, an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national reports on life sciences.More.

SPECIAL REPORT: Indiana companies charge into China

With economic growth in the United States sluggish, Indiana companies are joining the race to capitalize on the fast-growing Chinese economy—even as hundreds of millions of Chinese move into the middle class and adopt a Western-style thirst for goods and services.More.

Hospitals suffer from spiking bond interest rates, investment lossesRestricted Content

Indianapolis-area hospitals have suffered a double whammy of spiking interest rates on their bonds and heavy losses in their investment portfolios and are trying to save cash any way they can.More.

In Depth Reports

Sponsored by
Subscribe to IBJ